You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

Details for Patent: 9,399,775


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,399,775 protect, and when does it expire?

Patent 9,399,775 protects AMVUTTRA and is included in one NDA.

This patent has one hundred patent family members in thirty-nine countries.

Summary for Patent: 9,399,775
Title:RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
Abstract: The present invention provides RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene and methods of using such RNAi agents for treating or preventing TTR-associated diseases.
Inventor(s): Rajeev; Kallanthottathil G. (Cambridge, MA), Zimmermann; Tracy (Cambridge, MA), Manoharan; Muthiah (Cambridge, MA), Maier; Martin (Cambridge, MA), Kuchimanchi; Satyanarayana (Cambridge, MA), Charisse; Klaus (Cambridge, MA)
Assignee: Alnylam Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:14/358,972
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Device;

Drugs Protected by US Patent 9,399,775

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alnylam Pharms Inc AMVUTTRA vutrisiran sodium SOLUTION;SUBCUTANEOUS 215515-001 Jun 13, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y AMVUTTRA IS INDICATED FOR THE TREATMENT OF THE POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN ADULTS ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,399,775

PCT Information
PCT FiledNovember 16, 2012PCT Application Number:PCT/US2012/065691
PCT Publication Date:May 23, 2013PCT Publication Number: WO2013/075035

International Family Members for US Patent 9,399,775

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 088911 ⤷  Sign Up
Argentina 121312 ⤷  Sign Up
Australia 2012340159 ⤷  Sign Up
Australia 2017225076 ⤷  Sign Up
Australia 2019240658 ⤷  Sign Up
Australia 2022231749 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.